Insilico Medicine has hired Qingsong Zhu to serve as its chief operating officer. In this role, he will be in charge of the company's operations and drug discovery research initiatives.
Prior to joining the company, Zhu spent seven years as a postdoctoral research fellow in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and has also worked as an independent consultant to apply next-generation sequencing to develop diagnostics and personalized medicine. Zhu holds a bachelors degree in biology from the Beijing Forestry University in Beijing and doctorate in biochemistry from Kansas State University.